LS Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

LS Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,893	Closed	-$476K	–	445
2021 Q1	$476K	Sell	2,893 -610	-17%	-$100K	0.03%	397
2020 Q4	$578K	Buy	3,503 +408	+13%	+$60.8K	0.03%	382
2020 Q3	$441K	Buy	+3,095	New	+$384K	0.03%	426
2020 Q2	–	Sell	-148	Closed	-$15K	–	1676
2020 Q1	$15K	Sell	148 -625	-81%	-$80.8K	﹤0.01%	1453
2019 Q4	$115K	Hold	773	–	–	0.01%	1067
2019 Q3	$99K	Hold	773	–	–	0.01%	1070
2019 Q2	$110K	Hold	773	–	–	0.01%	1049
2019 Q1	$111K	Hold	773	–	–	0.01%	1044
2018 Q4	$96K	Hold	773	–	–	0.01%	1070
2018 Q3	$130K	Hold	773	–	–	0.01%	1037
2018 Q2	$133K	Hold	773	–	–	0.01%	1053
2018 Q1	$117K	Buy	773 +42	+6%	+$6.16K	0.01%	1074
2017 Q4	$98K	Hold	731	–	–	0.01%	1136
2017 Q3	$107K	Hold	731	–	–	0.01%	1138
2017 Q2	$114K	Hold	731	–	–	0.01%	1095
2017 Q1	$106K	Hold	731	–	–	0.01%	1098
2016 Q4	$80K	Hold	731	–	–	0.01%	1117
2016 Q3	$89K	Sell	731 -461	-39%	-$62.1K	0.01%	1036
2016 Q2	$168K	Hold	1,192	–	–	0.01%	826
2016 Q1	$156K	Buy	1,192 +194	+19%	+$24.1K	0.01%	702
2015 Q4	$140K	Buy	998 +157	+19%	+$21.8K	0.01%	735
2015 Q3	$112K	Hold	841	–	–	0.01%	804
2015 Q2	$148K	Hold	841	–	–	0.01%	711
2015 Q1	$145K	Hold	841	–	–	0.01%	639
2014 Q4	$138K	Buy	+841	New	+$140K	0.01%	643

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LS Investment Advisors's JAZZ Position: Q2 2021 in Review

LS Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 2,893 shares — an estimated $476K sold.

LS Investment Advisors first reported a position in JAZZ in Q4 2014 and held it in 25 quarters. The position peaked at $578K in Q4 2020. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

LS Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
LS Investment Advisors sold 2,893 Jazz Pharmaceuticals shares in Q2 2021, an estimated $476K.
LS Investment Advisors first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 25 quarters.
LS Investment Advisors's Jazz Pharmaceuticals position peaked at $578K in Q4 2020.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.